Literature DB >> 25371362

SOX9 accelerates ESC differentiation to three germ layer lineages by repressing SOX2 expression through P21 (WAF1/CIP1).

Kohei Yamamizu1, David Schlessinger1, Minoru S H Ko2.   

Abstract

Upon removal of culture conditions that maintain an undifferentiated state, mouse embryonic stem cells (ESCs) differentiate into various cell types. Differentiation can be facilitated by forced expression of certain transcription factors (TFs), each of which can generally specify a particular developmental lineage. We previously established 137 mouse ESC lines, each of which carried a doxycycline-controllable TF. Among them, Sox9 has unique capacity: its forced expression accelerates differentiation of mouse ESCs into cells of all three germ layers. With the additional use of specific culture conditions, overexpression of Sox9 facilitated the generation of endothelial cells, hepatocytes and neurons from ESCs. Furthermore, Sox9 action increases formation of p21 (WAF1/CIP1), which then binds to the SRR2 enhancer of pluripotency marker Sox2 and inhibits its expression. Knockdown of p21 abolishes inhibition of Sox2 and Sox9-accelerated differentiation, and reduction of Sox2 2 days after the beginning of ESC differentiation can comparably accelerate mouse ESC formation of cells of three germ layers. These data implicate the involvement of the p21-Sox2 pathway in the mechanism of accelerated ESC differentiation by Sox9 overexpression. The molecular cascade could be among the first steps to program ESC differentiation.
© 2014. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cdkn1a (P21/WAF1/CIP1); Embryonic stem cells; Sox2; Sox9

Mesh:

Substances:

Year:  2014        PMID: 25371362      PMCID: PMC4302912          DOI: 10.1242/dev.115436

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  67 in total

1.  Epigenetic modifications of SOX2 enhancers, SRR1 and SRR2, correlate with in vitro neural differentiation.

Authors:  Marianna Sikorska; Jagdeep K Sandhu; Paromita Deb-Rinker; Anna Jezierski; Julie Leblanc; Claudie Charlebois; Maria Ribecco-Lutkiewicz; Mahmud Bani-Yaghoub; P Roy Walker
Journal:  J Neurosci Res       Date:  2008-06       Impact factor: 4.164

2.  MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells.

Authors:  Dasa Dolezalova; Marek Mraz; Tomas Barta; Karla Plevova; Vladimir Vinarsky; Zuzana Holubcova; Josef Jaros; Petr Dvorak; Sarka Pospisilova; Ales Hampl
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

3.  Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway.

Authors:  Makoto Saegusa; Miki Hashimura; Erina Suzuki; Tsutomu Yoshida; Takeshi Kuwata
Journal:  Am J Pathol       Date:  2012-06-12       Impact factor: 4.307

Review 4.  Generation and regeneration of cells of the liver and pancreas.

Authors:  Kenneth S Zaret; Markus Grompe
Journal:  Science       Date:  2008-12-05       Impact factor: 47.728

5.  Runx1 and p21 synergistically limit the extent of hair follicle stem cell quiescence in vivo.

Authors:  Jayhun Lee; Charlene S L Hoi; Karin C Lilja; Brian S White; Song Eun Lee; David Shalloway; Tudorita Tumbar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

6.  Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.

Authors:  Thierry Passeron; Julio C Valencia; Takeshi Namiki; Wilfred D Vieira; Hélène Passeron; Yoshinori Miyamura; Vincent J Hearing
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

7.  Systematic repression of transcription factors reveals limited patterns of gene expression changes in ES cells.

Authors:  Akira Nishiyama; Alexei A Sharov; Yulan Piao; Misa Amano; Tomokazu Amano; Hien G Hoang; Bernard Y Binder; Richard Tapnio; Uwem Bassey; Justin N Malinou; Lina S Correa-Cerro; Hong Yu; Li Xin; Emily Meyers; Michal Zalzman; Yuhki Nakatake; Carole Stagg; Lioudmila Sharova; Yong Qian; Dawood Dudekula; Sarah Sheer; Jean S Cadet; Tetsuya Hirata; Hsih-Te Yang; Ilya Goldberg; Michele K Evans; Dan L Longo; David Schlessinger; Minoru S H Ko
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data.

Authors:  Alexei A Sharov; Shinji Masui; Lioudmila V Sharova; Yulan Piao; Kazuhiro Aiba; Ryo Matoba; Li Xin; Hitoshi Niwa; Minoru S H Ko
Journal:  BMC Genomics       Date:  2008-06-03       Impact factor: 3.969

9.  SOX9: a stem cell transcriptional regulator of secreted niche signaling factors.

Authors:  Meelis Kadaja; Brice E Keyes; Mingyan Lin; H Amalia Pasolli; Maria Genander; Lisa Polak; Nicole Stokes; Deyou Zheng; Elaine Fuchs
Journal:  Genes Dev       Date:  2014-02-15       Impact factor: 11.361

10.  Identification of transcription factors for lineage-specific ESC differentiation.

Authors:  Kohei Yamamizu; Yulan Piao; Alexei A Sharov; Veronika Zsiros; Hong Yu; Kazu Nakazawa; David Schlessinger; Minoru S H Ko
Journal:  Stem Cell Reports       Date:  2013-11-27       Impact factor: 7.765

View more
  10 in total

1.  The role of Sox9 in maintaining the characteristics and pluripotency of Arbas Cashmere goat hair follicle stem cells.

Authors:  Nimantana He; Zhenguo Dong; Dapeng Tai; Hao Liang; Xudong Guo; Ming Cang; Dongjun Liu
Journal:  Cytotechnology       Date:  2018-03-14       Impact factor: 2.058

2.  nNOS Translocates into the Nucleus and Interacts with Sox2 to Protect Neurons Against Early Excitotoxicity via Promotion of Shh Transcription.

Authors:  Dongmei Zhang; Hongmei Wang; Hanzhang Liu; Tao Tao; Ning Wang; Aiguo Shen
Journal:  Mol Neurobiol       Date:  2015-11-25       Impact factor: 5.590

Review 3.  G1-phase progression in pluripotent stem cells.

Authors:  Menno Ter Huurne; Hendrik G Stunnenberg
Journal:  Cell Mol Life Sci       Date:  2021-04-21       Impact factor: 9.261

4.  Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A.

Authors:  Wiktoria Maria Suchorska; Ewelina Augustyniak; Magdalena Richter; Tomasz Trzeciak
Journal:  Mol Med Rep       Date:  2017-03-16       Impact factor: 2.952

5.  NF-κB Activity Initiates Human ESC-Derived Neural Progenitor Cell Differentiation by Inducing a Metabolic Maturation Program.

Authors:  Lorna M FitzPatrick; Kate E Hawkins; Juliette M K M Delhove; Emilio Fernandez; Chiara Soldati; Louise F Bullen; Axel Nohturfft; Simon N Waddington; Diego L Medina; Juan P Bolaños; Tristan R McKay
Journal:  Stem Cell Reports       Date:  2018-04-19       Impact factor: 7.294

Review 6.  Cycling to Meet Fate: Connecting Pluripotency to the Cell Cycle.

Authors:  Lamuk Zaveri; Jyotsna Dhawan
Journal:  Front Cell Dev Biol       Date:  2018-06-19

Review 7.  The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy.

Authors:  Nina-Naomi Kreis; Frank Louwen; Juping Yuan
Journal:  Cancers (Basel)       Date:  2019-08-21       Impact factor: 6.639

Review 8.  Vertebrate Cell Differentiation, Evolution, and Diseases: The Vertebrate-Specific Developmental Potential Guardians VENTX/NANOG and POU5/OCT4 Enter the Stage.

Authors:  Bertrand Ducos; David Bensimon; Pierluigi Scerbo
Journal:  Cells       Date:  2022-07-26       Impact factor: 7.666

9.  Regulation of both transcription and RNA turnover contribute to germline specification.

Authors:  Kun Tan; Miles F Wilkinson
Journal:  Nucleic Acids Res       Date:  2022-07-22       Impact factor: 19.160

10.  Embryonic stem cell-derived extracellular vesicles promote the recovery of kidney injury.

Authors:  Lu Yu; Siying Liu; Chen Wang; Chuanyu Zhang; Yajie Wen; Kaiyue Zhang; Shang Chen; Haoyan Huang; Yue Liu; Lingling Wu; Zhongchao Han; Xiangmei Chen; Zongjin Li; Na Liu
Journal:  Stem Cell Res Ther       Date:  2021-07-02       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.